Topics
News
CME/CE
Editorial Advisory Board
Partners
Subscribe
- General Dermatology
- Eczema
- Chronic Hand Eczema
- Alopecia
- Aesthetics
- Vitiligo
- COVID-19
- Actinic Keratosis
- Precision Medicine and Biologics
- Rare Disease
- Wound Care
- Rosacea
- Psoriasis
- Psoriatic Arthritis
- Atopic Dermatitis
- Melasma
- NP and PA
- Skin Cancer
- Hidradenitis Suppurativa
- Drug Watch
- Pigmentary Disorders
- Acne
- Pediatric Dermatology
- Practice Management
- Prurigo Nodularis
Article
Fusion protein denileukin diftitox clears psoriasis
New York - The fusion protein denileukin diftitox appears effectivein stabilizing and clearing skin lesions in patients with psoriasis vulgaris,according to findings presented by James Krueger, M.D., Ph.D., head of theLaboratory for Investigative Dermatology, The Rockefeller University.
Related Videos
Related Content
